These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Theory of the Rh factor and its clinical significance]. SPEISER P; KOLBL H Wien Klin Wochenschr; 1952 Feb; 64(8):133-8. PubMed ID: 14922758 [No Abstract] [Full Text] [Related]
4. Duration of pregnancy in relationship to fetal survival rates in Rh immunized gravidae. JACOBS WM Med Rec Ann; 1962 Feb; 55():35. PubMed ID: 14450699 [No Abstract] [Full Text] [Related]
5. The rhesus factor (part 2). DUNDON S; O'DRISCOLL K; GEOGHEGAN F J Ir Med Assoc; 1952 Mar; 30(177):65-9. PubMed ID: 14927994 [No Abstract] [Full Text] [Related]
6. Fetal survival rates in Rh-immunized gravidas: correlation of antibody titers and past obstetric history. JACOBS WM Obstet Gynecol; 1962 Jun; 19():806-7. PubMed ID: 14450700 [No Abstract] [Full Text] [Related]
7. The foetal and neonatal wastage due to sensitization by the Rh factor. KELSALL GA; VOS GH Med J Aust; 1955 Feb; 42(1 8):261-3. PubMed ID: 14369211 [No Abstract] [Full Text] [Related]
8. [Hemolytic disease of the newborn due to Rh factor incompatibility. Results of a 31/2 year experience at the maternity department of the San Francisco de Borja Hospital]. VERA L; HILLE A Rev Chil Pediatr; 1960 May; 31():221-7. PubMed ID: 13841713 [No Abstract] [Full Text] [Related]
9. A survey of the ABO and Rhesus blood groups of pregnant women in Lagos with special reference to the observed and theoretical incidence of erythroblastosis foetalis. HARDY J West Afr Med J; 1962 Apr; 11():64-73. PubMed ID: 13904654 [No Abstract] [Full Text] [Related]
10. [Prevention of fetal erythroblastosis in pregnancy]. JOSEF C Cesk Gynekol; 1950; 15(4-5):353-64. PubMed ID: 15434864 [No Abstract] [Full Text] [Related]
11. The Rh factor and erythroblastosis fetalis. CROSS AR N C Med J; 1951 Sep; 12(9):426-7. PubMed ID: 14882631 [No Abstract] [Full Text] [Related]
13. Cortisone in Rh incompatibilities. HUNTER OB; ROSS JB South Med J; 1952 Aug; 45(8):732-8. PubMed ID: 12995133 [No Abstract] [Full Text] [Related]
14. [The Rh factor in obstetrics]. ATTENDU CA Union Med Can; 1952 Mar; 81(3):344-5. PubMed ID: 14950959 [No Abstract] [Full Text] [Related]
15. [Clinical significance of Rh factors]. MATTHES M Dtsch Med Wochenschr; 1952 Apr; 77(17):564-5. PubMed ID: 14936615 [No Abstract] [Full Text] [Related]
16. Further experimental studies on the prevention of Rh haemolytic disease. CLARKE CA; DONOHOE WT; McCONNELL RB; WOODROW JC; FINN R; KREVANS JR; KULKE W; LEHANE D; SHEPPARD PM Br Med J; 1963 Apr; 1(5336):979-84. PubMed ID: 14021558 [No Abstract] [Full Text] [Related]
17. [Hemolytic disease in the newborn infant]. VERA L; HILLE A Rev Chil Pediatr; 1961; 32():111-4. PubMed ID: 13780756 [No Abstract] [Full Text] [Related]
18. [On the possibilities of practical application of the results of research on the Rh factor in fetal erythroblastosis]. DAHR P Dtsch Gesundheitsw; 1951 May; 6(22):613-8. PubMed ID: 14849337 [No Abstract] [Full Text] [Related]
19. The occurrence of kernicterus in an autopsy material. AHVENAINEN EK; NEVANLINNA HR Acta Pathol Microbiol Scand Suppl (1926); 1952 Jun; 93():206. PubMed ID: 13030251 [No Abstract] [Full Text] [Related]